Neurogene (NGNE) Change in Acquisitions & Divestments (2014 - 2026)

Neurogene (NGNE) has 10 years of Change in Acquisitions & Divestments data on file, last reported at $130.0 million in Q1 2026.

• Quarterly Change in Acquisitions & Divestments rose 190.83% year-over-year to $130.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $370.0 million (up 317.14% YoY) and the FY2025 annual result came in at $284.7 million, up 284.73% from the prior year.
• Change in Acquisitions & Divestments rose to $130.0 million in Q1 2026, from $72.5 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $130.0 million in Q1 2026 to a low of -$15.0 million in Q4 2022.
• A 5-year average of $41.1 million and a median of $24.8 million in 2024 frame the typical range for Change in Acquisitions & Divestments.
• The widest YoY moves for Change in Acquisitions & Divestments: up 1037.14% in 2025, down 49.0% in 2025.
• Tracing NGNE's Change in Acquisitions & Divestments over 5 years: stood at -$15.0 million in 2022, then soared by 133.33% to $5.0 million in 2023, then soared by 215.0% to $15.8 million in 2024, then surged by 360.32% to $72.5 million in 2025, then soared by 79.31% to $130.0 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $130.0 million (Q1 2026), $72.5 million (Q4 2025), and $99.5 million (Q3 2025), per Business Quant data.